ReviewClinical journal of the American Society of Nephrology : CJASN2016
Urinary Stone Disease: Advancing Knowledge, Patient Care, and Population Health.
Review in Clinical journal of the American Society of Nephrology : CJASN, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
97 citing papers in PubMed, 2 syntheses or guidelines pooled it, 181 citations in OpenAlex.
- Costs of resolving a ureteral or kidney stone episode worldwide: a systematic review.International urology and nephrology · 2026Pooled it
- Prevalence and clinical patterns of urolithiasis in sub-saharan Africa: a systematic review and meta-analysis of observational studies.BMC nephrology · 2024Pooled it
- Acoustic Enhancer Microbubble Cavitation: A Randomized Clinical Trial Evaluating the Safety and Efficacy of a Novel Treatment for Urolithiasis.The Journal of urology · 2025Trial
- Using structured problem solving to promote fluid consumption in the prevention of urinary stones with hydration (PUSH) trial.BMC nephrology · 2024Trial
- Role of FGF23 in Pediatric Hypercalciuria.BioMed research international · 2017Trial
- A qualitative exploration of occupational influences on hydration, urination habits, food patterns, and self-care among patients with urolithiasis.BMC nephrology · 2026Observational
- Association between oxidative balance score, genetic susceptibility and nephrolithiasis: a cohort study based on the UK Biobank.European journal of nutrition · 2026Article
- 3D Passive Cavitation Mapping (3D-PCM) with a Large-aperture Planar Array.bioRxiv : the preprint server for biology · 2026Article
- Drug-drug interaction signals between carbonic anhydrase inhibitors and vitamin D preparations in urinary tract stones: disproportionality analysis evaluation from Japanese spontaneous reports of adverse events.Journal of pharmaceutical health care and sciences · 2026Article
- Risk Factors for Upper Urinary Tract Stone Recurrence: A Retrospective Study of 247 Patients.Medical science monitor : international medical journal of experimental and clinical research · 2026Article
- Gaps in knowledge and prevention of kidney stone disease among Palestinian adults: findings from an online cross-sectional survey.BMC public health · 2026Article
- Ten tips on the work-up and management of CKD patients with nephrolithiasis.Clinical kidney journal · 2026Review
- Revolutionizing nephrocalcinosis treatment: IL-10 engineered macrophages as a novel therapeutic approach.Bioengineering & translational medicine · 2026Article
- Claims-based Approach to Defining Renal Colic Episodes: Implications for Researchers, Providers, and Policymakers.Urology · 2026Article
- Kidney stone disease: risk factors, pathophysiology and management.Nature reviews. Nephrology · 2025Review
- Imaging during pediatric stone management and follow up.World journal of urology · 2025Review
- Global, Regional, and National Epidemiology of Pediatric Urolithiasis (1990-2021) and 2040 Forecast.The Journal of urology · 2025Article
- Temporal trends and projections of urolithiasis in China and globally from 1990 to 2030: insights from the global burden of disease study 2021.Urolithiasis · 2025Article
- Association between kidney stones and urological cancers: results from the NHANES 2007-2020 and Mendelian randomization study.Discover oncology · 2025Article
- Article
37 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 5 institutions in 1 country.
Funding
Abstract
Expanding epidemiologic and physiologic data suggest that urinary stone disease is best conceptualized as a chronic metabolic condition punctuated by symptomatic, preventable stone events. These acute events herald substantial future chronic morbidity, including decreased bone mineral density, cardiovascular disease, and CKD. Urinary stone disease imposes a large and growing public health burden. In the United States, 1 in 11 individuals will experience a urinary stone in their lifetime. Given this high incidence and prevalence, urinary stone disease is one of the most expensive urologic conditions, with health care charges exceeding $10 billion annually. Patient care focuses on management of symptomatic stones rather than prevention; after three decades of innovation, procedural interventions are almost exclusively minimally invasive or noninvasive, and mortality is rare. Despite these advances, the prevalence of stone disease has nearly doubled over the past 15 years, likely secondary to dietary and health trends. The NIDDK recently convened a symposium to assess knowledge and treatment gaps to inform future urinary stone disease research. Reducing the public health burden of urinary stone disease will require key advances in understanding environmental, genetic, and other individual disease determinants; improving secondary prevention; and optimal population health strategies in an increasingly cost-conscious care environment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.